SCHEMBL6740953

SCHEMBL6740953

Cc1cccc(C#N)c1C[O]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 1/20 0.35
MCL1 Q07820 1/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
HTT P42858 1/20 0.34
AR P10275 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
GAA P10253 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6743455 0.85 CA1 (0.42) TSHRCA1CA2ALDH1A1KDM4E
SCHEMBL1922926 0.82 TSHR (0.56) TSHRTDP1MEN1MAPTKMT2A
SCHEMBL7357997 0.80 TSHR (0.54) TSHRTDP1MEN1MAPTKMT2A
Water SCHEMBL8703025 0.80 TSHR (0.54) TSHRTDP1MEN1MAPTKMT2A
SCHEMBL6739582 0.80 TSHR (0.54) TSHRCA1CA2TDP1MEN1
SCHEMBL6351539 0.80 TSHR (0.54) TSHRCA1CA2TDP1MEN1
SCHEMBL6471566 0.78 TSHR (0.47) TSHRMEN1MAPTKMT2AALDH1A1
SCHEMBL395822 0.78 CYP1A2 (0.43) TSHRCA1CA2TDP1MEN1
SCHEMBL12490636 0.77 TSHR (0.50) TSHRCA1CA2TDP1MEN1
SCHEMBL28234295 0.77 TSHR (0.50) TSHRTDP1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6610731-B2 Antiinflammatory BRISTOL-MYERS SQUIBB COMPANY 2003-08-26 US disclosed
US-6403632-B1 CYCLIC AMIDE DERIVATIVE BRISTOL MYERS SQUIBB PHARMA CO (US) 2002-06-11 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed
US-6057336-A ANTIINFLAMMATORY AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-05-02 US disclosed